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Abstract
Pathogens represent a universal threat to other living organisms. Most organisms express antimicrobial proteins and
peptides, such as lysozymes, as a protection against these challenges. The nematode Caenorhabditis elegans harbours 15
phylogenetically diverse lysozyme genes, belonging to two distinct types, the protist- or Entamoeba-type (lys genes) and
the invertebrate-type (ilys genes) lysozymes. In the present study we characterized the role of several protist-type lysozyme
genes in defence against a nematocidal strain of the Gram-positive bacterium Bacillus thuringiensis. Based on microarray and
subsequent qRT-PCR gene expression analysis, we identified protist-type lysozyme genes as one of the differentially
transcribed gene classes after infection. A functional genetic analysis was performed for three of these genes, each
belonging to a distinct evolutionary lineage within the protist-type lysozymes (lys-2, lys-5, and lys-7). Their knock-out led to
decreased pathogen resistance in all three cases, while an increase in resistance was observed when two out of three tested
genes were overexpressed in transgenic lines (lys-5, lys-7, but not lys-2). We conclude that the lysozyme genes lys-5, lys-7,
and possibly lys-2 contribute to resistance against B. thuringiensis, thus highlighting the particular role of lysozymes in the
nematode’s defence against pathogens.
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Introduction
Lysozymes are small enzymes, which can cleave peptidoglycan,
an essential component of bacterial cell walls. They are found in
almost all groups of organisms and play important roles in both
immunity and digestion [1–6]. In several organisms including the
Caenorhabditis taxon the evolution of lysozymes is characterized by
gene duplication and adaptive sequence evolution, leading to
substantial intra-specific enzyme diversification [7–10]. C. elegans is
of particular interest in this context, because its genome contains
15 phylogenetically diverse lysozyme genes, the largest number
recorded to date [10].
C. elegans lysozymes are of two distinct types, the invertebrate- (ilys
genes) and the protist- or Entamoeba-type (lys genes). The latter
group further diverges into two distinct clades [10]. Representative
members of the two main types are known from other organisms to
act as functional antimicrobial enzymes [11,12], suggesting that
they have a similar function in C. elegans. In the nematode, the
encountered genetic diversity may reflect functional diversity [10],
in a similar way to that demonstrated for the antimicrobial nlp genes
[13]. To date, only little information is available on the exact
function of lysozymes in C. elegans immunity. All available data is
based on genetic analysis, whereas none of the lysozymes have been
characterized at the protein level. In particular, four lysozyme genes
were directly shown by overexpression and mutant or RNAi-knock
down analysis to contribute to the nematode’s defence against
pathogens: lys-1 against Serratia marcescens and Staphylococcus aureus
[14,15]; lys-2 against Pseudomonas aeruginosa [16]; lys-7 against
Microbacterium nematophilum, P. aeruginosa, Salmonella Typhimurium,
the pathogenic Escherichia coli strain LF82, and Cryptococcus neoformans
[16–20], and ilys-3 against M. nematophilum [17]. In addition, seven
other lysozymes have been implicated in immunity because
exposure of C. elegans to various pathogens leads to changes in their
transcription patterns [10,21–25].
In the present study we focused on the role of protist-type
lysozymes in C. elegans defence against the Gram-positive
bacterium B. thuringiensis (Bt). Bt infects invertebrate hosts in a
highly specialized process. The bacterium’s infectious stages are
spores associated with crystal toxins (Cry and Cyt toxins). After
oral uptake of the spore-toxin mixture by a suitable host organism
such as insects or nematodes, toxin solubilisation occurs inside the
gut. The solubilised toxins specifically bind to glycolipids of
intestinal cells [26–29], followed by formation of membrane pores
and subsequent cellular disintegration [30]. Cell destruction
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24619appears to lead to a change in milieu (e.g., change of gut pH in
insects) that triggers germination of spores and vegetative
proliferation of bacteria [30,31]. Most Bt strains express several
different toxin genes [31,32]. Overall, Bt produces an enormously
diverse array of toxins and hence the taxon includes strains with
high specificity towards different hosts including free-living
nematodes such as C. elegans [33–35]. The nematode-specific Bt
strains can establish persistent infections in C. elegans under
laboratory conditions, even if the environmental medium does not
support bacterial growth [33–36]. Some Bt strains are able to
produce highly specific interactions with different natural C. elegans
isolates [37,38], suggesting that the two coexist in nature.
Previous studies characterized in much detail the nematode’s
defence against one of the nematocidal Bt toxins, namely Cry5B.
The toxin binds to glycolipids on membranes of the epithelial cells
in the intestine. Thus, alteration of these glycolipids and
competitive binding of galectins to these glycolipids mediates
resistance [26–29,39,40]. Resistance is also influenced by plasma
membrane repair, as mediated by RAB-5- and RAB-11-
dependent vesicle trafficking pathways [41]. Moreover, whole-
genome microarray-based gene expression analyses and a recent
RNAi knock-down screen revealed the involvement of a regulatory
defence network based on two mitogen-activated protein kinase
(MAPK) pathways, namely the p38 and JNK-like MAPK, and the
activating protein 1 (AP-1) transcription factor [42,43]. Protection
against Bt toxins is additionally influenced by the hypoxia response
and the insulin-like signaling pathways [44,45]. The latter pathway
also mediates both physiological defence and behavioural
avoidance of a toxin-spore mixture of the pathogenic Bt strain
B-18247 [46].
Here, we used microarrays to identify candidate immune
effector genes in the C. elegans response against the nematocidal Bt
strain B-18247, which is known to possess several different toxin
genes [47–49]. Differential gene transcription was studied in three
different natural C. elegans isolates (N2, MY15, and MY18), which
show similar resistance to B-18247 (unpublished data), but have
distinct genetic backgrounds [50], thus allowing identification of
common principles in the genetic basis of resistance. As our
transcriptional analysis identified a comparatively large number of
protist-type lysozymes to be differentially regulated, we specifically
tested the role of three lysozyme genes (lys-2, lys-5, lys-7) using
knock-out mutants and gene overexpression in transgenic strains.
The results strongly suggest a function of these lysozyme genes,
especially of lys-5 and lys-7, in the nematode’s defence against
pathogenic Bt.
Results
The transcriptional signature of Bt infected C. elegans
reveals differentially regulated protist-type lysozymes
We explored the transcriptional responseof three C. elegans strains
(N2 and the two natural isolates MY15 and MY18) after 8 h
exposure to the infectious spore-toxin mixture of the nematocidal Bt
strain B-18247. The 8 h time point was specifically chosen, because
it is sufficiently long after first pathogen exposure for an immune-
relevant transcriptional response to develop [51], including the
response against Bt toxin [43], and because it is well before the
occurrence of Bt-induced host mortalities (.12 h after first
exposure, unpublished data), which themselves associate with
substantial transcriptional changes and thus could seriously
complicate interpretation of inducible gene expression analysis [52].
Based on statistical analysis using F tests implemented in the R/
MAANOVA package [53,54], we obtained a list of significantly
differentially transcribed genes. Although the three strains vary in
their response, there is also substantial overlap in the differentially
regulated individual genes (Table S1 and Table S2 in supporting
information). Since transcription was studied in three genotypi-
cally different C. elegans strains, the overlapping gene set most likely
represents the core set of genes that is inducible by the infectious
Bt spore-toxin mixture. One of the prominent gene classes within
this gene set are the protist-type lysozymes. Interestingly, some of
them were consistently up- and others were consistently down-
regulated after exposure to the Bt spore-toxin mixture. In detail,
significant upregulation was found for lys-1 and lys-2 in all three C.
elegans strains and, additionally, for lys-3 in the two recent natural
isolates MY15 and MY18 (Table S1, Table S2). Significant
downregulation was inferred for lys-4 and lys-5 in all three strains,
for lys-10 in strains MY15 and MY18, and for lys-7 in MY18
(Table S1, Table S2).
Differential gene expression of the protist-type lysozymes was
subsequently reassessed using quantitative reverse transcription
real-time PCR (qRT-PCR). The qRT-PCR fold induction values
were calculated with the 2
2DDCT method [55] and clearly differed
among genes (Figure 1). More importantly, they generally
validated the microarray results (Table S1, Table S2, Figure 1).
The exceptions included significant upregulation of lys-3 in N2,
and significant downregulation of lys-7 in MY18 and N2, and lys-
10 in N2, which we consistently inferred by qRT-PCR (Figure 1)
but not by microarray analysis. Note that even though the
microarrays contained oligos for almost all protein-coding genes of
the C. elegans genome (20,334 genes), unfortunately the lys-6 gene
was not included. Thus, for this gene we only have results from
qRT-PCR analysis. Taken together, our results suggest that
exposure to the Bt spore-toxin mixture leads to upregulation of
three closely related lysozyme genes and, at the same time,
downregulation of five other lysozymes, of which four belong to
the same evolutionary lineage (Figure 1), possibly indicating
functional divergence of the lysozymes across the genealogical tree.
Protist-type lysozymes influence resistance against Bt
We tested the idea of functional diversification using phenotypic
analysis of Bt infected C. elegans knock-out mutants and transgenic
worms overexpressing lysozyme genes. In particular, the resistance
function of three lysozyme genes was evaluated, belonging to the
three distinct protist-type lysozyme clades (Figure 1) and including
one of the upregulated genes (lys-2) and two of the downregulated
genes (lys-5 and lys-7). Phenotypic effects on pathogen defence
were determined by measuring survival rate, infection load, body
size, feeding rate, and population size. In the presence of
pathogenic Bt, all three knock-out mutants showed significantly
decreased survival when compared to the wild-type N2 (Figure 2,
Table S3 in supporting information). Moreover, the lys-5(tm2439)
mutant also suffered from significantly higher infection load than
N2 (Figure 3, Table S3), whereas the other two mutants did not
vary significantly from the wild-type. On pathogenic Bt, none of
the mutants differed significantly from the wild-type N2 regarding
body size, feeding rate, and population size (Figure 3, Figure 4,
Table S3). We did not observe any significant differences among
strains on the non-pathogenic Bt control (Figure 2, Figure 3,
Figure 4).
We additionally tested lysozyme function by overexpressing the
three genes in the N2 wild-type background. When exposed to the
pathogenic Bt strain B-18247, overexpression of lys-7 led to
significantly higher survival rates than observed for the correspond-
ing lys-7 knock-out mutant and also the N2 wild-type (Figure 5,
Table S4 in supporting information). Overexpression of lys-5
resulted in significantly increased survival only relative to the
corresponding lys-5 knock-out mutant but not N2, whereas lys-2
Role of C. elegans Lysozymes in Bt Resistance
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out or N2 (Figure 5, Table S4). There was no significant variation
among strains exposed to the non-pathogenic Bt control (Figure 5).
Discussion
In the present study we employed whole genome microarrays to
explore the involvement of candidate immune effectors in the
nematode’s inducible defence against a nematocidal strain of the
Gram-positive bacterium Bacillus thuringiensis. During this analysis,
we specifically controlled three critical but often neglected
variables: (i) Rather than using the standard food source E. coli
as a control, we exposed nematodes to the spore-toxin mixture of a
Bt strain (DSM-350) that does not infect nematode host tissue or
reduce C. elegans survival [36,46]. (ii) We always added E. coli as an
ad libitum food source to both pathogen and control treatments.
These first two points served to ensure that the observed inducible
transcriptional response is specific to the nematocidal pathogenic-
ity of the bacterium and is unlikely to be compromised by
taxonomic differences between test and control bacterial species or
the availability of food. (iii) We focused on differential transcription
after 8 h exposure – before first pathogen-induced mortalities
occur (usually not before 12 h after exposure’, unpublished
results), which could bias transcriptional inferences [52], and, at
the same time, after inducible defence responses should have had
the time to develop [51], including those against Bt toxin [43].
Our transcriptome analysis identified lysozyme genes to be
among the differentially transcribed gene classes, suggesting a role
in pathogen defence. For a more detailed analysis, we focused on
the protist-type lysozymes. Interestingly, the groups of up- versus
down-regulated genes fall into distinct evolutionary lineages
(Figure 1), possibly suggesting an evolutionary differentiation of
gene function upon gene duplication as previously proposed [10].
In particular, we expected a role of the up-regulated lysozyme
genes in immune defence against pathogenic Bt, whereas the
downregulated lysozymes should not be required under these
conditions but under non-pathogenic conditions may have a
different function, for example as digestive enzymes [10]. In our
study, both treatments included a suitable food source (E. coli). If
the presence of pathogens is speculated to inhibit expression of
digestive enzymes, then their absence under control conditions
and the simultaneous presence of food could have elicited a
digestive response. Under these assumptions, the lysozyme genes
of particular importance for digestion could appear as a
downregulated gene set under pathogen conditions even if they
are of no relevance to the nematode’s response to pathogens.
The results from our functional genetic analysis disagree with
our expectations. This analysis specifically focused on three genes
(lys-2, lys-5, lys-7) as representatives of the up- as well as down-
regulated gene classes and also of the three distinct evolutionary
lineages of the protist-type lysozyme genealogy [10]. Manipulation
of these three genes consistently produced similar phenotypes:
Knock-out mutations resulted in significantly reduced resistance
measures during exposure to pathogenic Bt, whereas the
overexpression of at least lys-5 and lys-7 consistently led to
significantly higher survival rates on the pathogen (Figures 2, 3, 4,
5). At the same time, strains did not vary significantly on the non-
pathogenic Bt control, indicating that the observed variation on
the pathogen is unlikely due to a general deficiency of the mutants
(Figures 2, 3, 4, 5). Moreover, the KO mutants also did not vary
significantly in feeding behaviour on the pathogen (Figure 4),
which argues against a role of the mutations in behavioural
defence such as the pathogen-induced reduction in ingestion [56].
Consequently, the observed variation on the pathogen strongly
suggests a function of the tested lysozymes in physiological
immunity. Our findings then also suggest that pathogen-
dependent gene expression patterns are not necessarily indicative
of a gene’s role in defence, especially in case of gene
downregulation after pathogen exposure. Defence genes may be
present in the downregulated gene set if the pathogen directly
interferes with its expression as part of its attempt to compromise
host resistance and thus facilitate invasion. Such interference with
the host’s immune system is known for a large variety of pathogen
taxa [57], including P. aeruginosa in a C. elegans host model [58].
Another non-exclusive explanation may be that the downregulated
lysozymes are part of the constitutively expressed (rather than
inducible) immune system and that their transcription is decreased
upon pathogen-mediated damage.
Figure 1. Information on lysozymes including their phyloge-
netic relationships and Bt-induced expression profiles. The
phylogeny shown in (A) is derived from previously published
phylogenetic analysis [10]. Expression profiles are given in (B) and
were established from quantitative realtime PCR. The three C. elegans
strains (MY15, MY18, N2) were confronted either with pathogenic or
non-pathogenic Bt for 8 h. Lysozyme induction is given as the
normalized expression difference between pathogen and non-patho-
gen treatment, such that positive values indicate upregulation and
negative values downregulation after pathogen exposure. Relative
expression levels were calculated from crossing points following the
2
2DDCT method (see methods section). Reddish/yellowish bar colours
refer to the lysozymes from chromosome V (lys-1, lys-2, lys-3, and lys-7),
bluish colours to those from chromosome IV (lys-4, lys-5, lys-6, and lys-
10), and green to that from chromosome II (lys-8). An expression
difference of 2 or 22 is indicated by dashed vertical lines. Stars
highlight groups that are significantly different from 0 according to a t
test and false-discovery-rate adjusted significance levels (all groups with
the exception of the three lys-8 groups and lys-2 from MY15).
doi:10.1371/journal.pone.0024619.g001
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approach, we conclude that at least the lysozyme genes lys-5 and
lys-7 contribute to physiological immunity against B. thuringiensis.
For lys-2, a resistance function is indicated by the knock-out
analysis, whereas its overexpression does not lead to a change in
phenotype. The latter finding may suggest that endogenous
expression levels for this gene (as shown by the wild-type N2) are
sufficient for maximal resistance to Bt-induced killing. Taken
together, our study adds to our understanding of the putative
immune effector repertoire of C. elegans and the particular role of
lysozymes in this context. Here, it is of interest that none of the
previous genetic analyses obtained an indication for a defence
function of lys-5 [10]. A possible reason is that most studies based
on a microarray-transcriptome approach for identification of
candidate immunity genes focus on the upregulated gene sets. If
lys-5 generally tends to be downregulated in response to pathogen
exposure, as in our study, then its role in defence would not have
been evaluated using functional genetic analysis. In fact, lys-5
transcription was previously found to be decreased in response to
pathogenic P. aeruginosa, but in this case the gene was not included
in the subsequent genetic analysis [51]. For lys-2 and lys-7,a
function in defence against B. thuringiensis was previously unknown.
At the same time, these genes, especially lys-7, were implicated in
resistance against other pathogens [16–20], suggesting that either
both of them or at least lys-7 play a more central role in C. elegans
immunity.
We would like to emphasize that our study (and most previous
studies) only indicates, but does not strictly prove a defence
function of these enzymes. Unequivocal evidence would require
analysis of the purified protein, especially its ability to interact with
the pathogen at the molecular level. In fact, such unequivocal
evidence is as yet only available for a single C. elegans immune
effector, namely the saposin-like caenopore SPP-5. For this
caenopore, it was possible to solve its tertiary structure and, most
importantly, its ability to form pores into bacterial cell membranes
[59,60]. Such biochemical studies remain a particular but
necessary challenge for an exact understanding of C. elegans
immune effectors.
Figure 2. Survival of C. elegans knock-out strains. Survival rate was studied on (A) the nematocidal Bt strain B-18247 or (B) the non-nematocidal
Bt strain DSM-350. It was checked daily for a period of 7 days. Every other day worms were transferred to fresh treatment plates. The C. elegans
wildtype N2 was compared to the mutants with lysozyme knock-out alleles lys-2(tm2398), lys-5(tm2439), and lys-7(ok1384).
doi:10.1371/journal.pone.0024619.g002
Figure 3. Variation among knock-out strains in infection load
and body size. Infection load (A) and body size (B) were compared
after 8 h exposure among the wildtype N2 and the mutants with
lysozyme knock-out alleles lys-2(tm2398), lys-5(tm2439),a n dlys-
7(ok1384). Nematodes were confronted with the pathogenic Bt strain
B-18247 (panel A) or both the pathogenic strain and the non-
pathogenic strain DSM-350 (panel B). The results for infection load
are shown as box–plots, where the horizontal black line gives the
median and the boxes the interquartile range (25% of the data above
and below the median). Nomarski images show examples of body sizes
for the different strains and treatments. Detailed statistics are given in
Table S3.
doi:10.1371/journal.pone.0024619.g003
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Nematode and bacterial strains, general conditions of
experiments
The C. elegans strain N2 and two natural isolates from Germany,
MY15 and MY18[50], were used to study transcriptional variation.
The function of three lysozyme genes was investigated using knock-
out (KO) mutants (lys-2(tm2398), lys-5(tm2439), and lys-7(ok1384)),
produced by the Japanese National Bioresource Project for the
experimental animal ‘‘nematode C. elegans’’, coordinated by the
Shohei Mitani laboratory (Tokyo Women’s Medical College,
Tokyo, Japan), and the American C. elegans gene knockout
consortium (Oklahoma Medical Research Foundation). We con-
firmed that the mutants are homozygous for the respective deletions
by gene-specific PCRs (see allele information at Wormbase, www.
wormbase.org). Mutants were backcrossed five times to N2 and did
not show any apparent phenotypic aberrations under standard
laboratoryconditions.Strainsareavailablefrom the Caenorhabditis
Genetics Center (www.cbs.umn.edu/CGC/).
Independent transgenic lines were constructed for lys-2, lys-5 and
lys-7 in the N2 background: MY1021 (wt; yaEx16(lys-2::gfp; pmyo-
2::rfp)), MY1022 (wt; yaEx17(lys-5::gfp; pmyo-2::rfp)), and MY1017
(wt; yaEx12(lys-7::gfp; pmyo-2::rfp)). The lines were generated
following the PCR fusion approach [61], in each case including
Figure 4. Variation among knock-out strains in feeding rate and population size. Feeding rate (A) and population size (B) were studied for
the wildtype N2 and the mutants with lysozyme knock-out alleles lys-2(tm2398), lys-5(tm2439), and lys-7(ok1384). Nematodes were confronted with
either the pathogenic Bt strain B-18247 (results are found in the bottom part of each panel) or the non-pathogenic strain DSM-350 (top part of each
panel). Feeding rate was determined by counting grinder movements within a 20 sec period after 8 h exposure. Population size assays were initiated
with ten L4 larvae and the total number of worms were scored after five days. Results are shown as box–plots, where the horizontal black line gives
the median and the boxes the interquartile range (25% of the data above and below the median). Population size is shown in logarithmic scale.
doi:10.1371/journal.pone.0024619.g004
Figure 5. Survival of knock-out strains and corresponding transgenic lines with lysozyme overexpression. Survival was evaluated in
the presence of (A) the nematocidal Bt strain B-18247 or (B) the non-nematocidal Bt strain DSM-350. Survival was checked daily for a period of 7 days.
Every other day worms were transferred to fresh treatment plates. The transgenic lines overexpressed either lys-2, lys-5,o rlys-7 in the N2 genomic
background. The knock-out mutants had the following alleles: lys-2(tm2398), lys-5(tm2439), lys-7(ok1384).
doi:10.1371/journal.pone.0024619.g005
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upstreamregions:735 bpforlys-2,1422 bpforlys-5,and708 bpfor
lys-7), amplified with the following primers: Lys-2_for (59-taaa-
tatttccgatgtgattgtcg -39), Lys-2_nest (59-tgattgtcgataacctttttaacg-39),
Lys-2_gfprev (59- agtcgacctgcaggcatgcaagctgtttccgacaaatcctccga-
caacaa-39), Lys-5_for (59-aagtcacaacatgtggtagctgat-39), Lys-5_nest
(59-ttcacagttatgaattctgcgttt-39), Lys-5_gfprev (59-agtcgacctgcagg-
catgcaagcttggaatgtagttcatatcaac -39), Lys-7_for (59-gactttggtgcttag-
gaaagatg-39), Lys-7_nest (59-tagtattcagaacgtggcggttag-39), Lys-
7_gfprev (59- agtcgacctgcaggcatgcaagctaattttcagacttccttgcacaaat -
39). Germline transformation followed the standard approach [62],
using 5 ng/ml of the transgene and 30 ng/mlo ft h epmyo-2::rfp co-
injection marker. The resulting transgenic lines did not show any
phenotypic aberrations under standard laboratory conditions.
The pathogenic Bt strain NRRL B-18247 was obtained from
the Agricultural Research Service Patent Culture Collection
(United States Department of Agriculture, Peoria, IL, USA) and
the non-pathogenic strain DSM-350 from the German Collection
of Microorganisms and Cell Cultures (Deutsche Sammlung von
Mikroorganismen und Zellkulturen GmbH, Braunschweig, Ger-
many). A spore-toxin mixture was prepared for each strain as
previously described [36,63], aliquotted and stored at 220uC, at
which they preserve their activity for approximately a year
(unpublished data) [64]. Aliquots were freshly thawed before usage
in the different experiments.
Nematodes were maintained on nematode growth medium
(NGM) plates inoculated with E. coli OP50 following standard
protocols [65]. The experiments were carried out at 20uC with
hermaphroditic fourth instar larvae (L4) that were either exposed
to the pathogenic or the non-pathogenic Bt strain. E. coli strain
OP50 was always added ad libitum as an independent food source.
Peptone free medium (PF) was used instead of NGM in order to
prevent germination of the spores [46].
Pathogen exposure and RNA isolation
Cultures of the three nematode strains (MY15, MY18 and N2)
were synchronised developmentally by sodium hypochlorite
treatment [65]. Ca. 20,000 L4 nematodes were transferred to
PF plates (14.5 cm diameter), containing 2.86 ml of a 10:1 mixture
of E. coli OP50 and Bt in PBS buffer (either the pathogenic B-
18247 or the control DSM-350 strain; final Bt concentration of
1.5610
8 spores/ml). Each nematode strain was exposed for 8 h to
either pathogenic or non-pathogenic Bt in either three (strain N2)
or four independent replicates (strains MY15 and MY18).
Thereafter, nematodes were washed off, pelleted by centrifugation,
washed in 10 ml sterile Millipore H2O to remove external
bacteria, pelleted, snap-frozen in liquid nitrogen, followed by
addition of 1.5 ml Trizol (Invitrogen) on ice (4uC), RNA extraction
according to manufacturer’s instructions (Trizol, Invitrogen), and
storage of RNA isolates at 220uC.
Microarray analysis
Geneexpressionpatternswerecomparedbetweenpathogenicand
non-pathogenic treatments for the three C. elegans strains separately
(MY15, MY18, N2) using whole genome microarrays containing
oligonucleotide sequences of 20,334 genes, designed at the Genome
Sequencing Center (St. Louis, USA) and spotted on UltraGAPS
TM
slides (Corning) at the Plateforme Transcriptome (Marseille-Nice
ge ´nopole/CNRS/INRA; Sophia Antipolis, France). 10 mgt o t a l
RNA was employed for cDNA synthesis with SuperScript II Reverse
Transcriptase (SSII, Invitrogen) using oligo dT24-V primer (Sigma-
Aldrich) and aminoallyl-dUTP (Sigma-Aldrich) nucleotide analogs.
cDNA was purified with the Qiagen PCR purification kit and
labelled either with Cy 3 or Cy 5 mono-reactive dye packs
(Amersham). Two differentially labelled probes were hybridized to
the microarray slides at 45uC for 16 h in hybridization buffer
(1X SSC, 0.2% SDS, 7 mM Tris-Cl, 0.2 mg/mL yeast t-RNA
(Invitrogen), 0.2 mg/mL poly(A)DNA (Sigma-Aldrich)) Fluorescent
images were captured using ScanArray 4000XL (Perkin Elmer) and
quantifiedwiththesoftwareQuantArrayversion 2.1(PerkinElmer).
Cy 3/Cy 5 dyes were swapped between Bt treatments across the
independent replicates. The microarray data is described in
accordance with MIAME guidelines and deposited at Array
Express (accession number E-MEXP-2168; http://www.ebi.ac.uk/
microarray-as/ae/).
Microarray signal intensities were normalized in three steps. We
first subtracted average background fluorescence for each spot.
Thereafter, data were transformed with the programme R/
MAANOVA [54], using first the rlowess and then the linlog
transformation [54,66]. Differential gene expression was assessed
with a mixed regression model, including pathogen as a fixed and
array as a random factor using the restricted maximum likelihood
(REML) approach [53,54,67]. The pathogen effect was evaluated
with an F3-test using a pooled estimator of the error-variance
[53,54] and comparison of the tabulated p-values with the F
distribution rather than a permutation analysis, which was
unsuitable for our study because of low sample size (maximum of
four replicates). To correct for multiple testing we adjusted the
significancelevelwiththehelpofthe falsediscoveryrate(FDR)[68].
Quantitative Realtime-PCR (RT-PCR)
Microarray-based transcription changes were specifically eval-
uated for nine protist-type lysozyme genes with quantitative
reverse transcriptase Realtime PCR (RT-PCR). The expression
patterns were compared between pathogenic and control treat-
ments for each strain (MY15, MY18, N2) and, in each case, three
independent replicates. The lysozymes were amplified with gene-
specific primers (Table 1). Their expression was normalized by
comparison with expression of the elongation factor 1a-homo-
logue K07A12.4 (EF) reference gene.
For the strains MY15 and MY18, cDNA was synthesized at
42uC for 1 h using 5 mg total RNA, 16first strand buffer, 10 mM
DTT, 1 mM dNTP, 1 mM Capfinder primer CFB1-rG (59-
GAGAGAACGCGTGACGAGAGAGACTGACArGrGrG -39),
1 mM dT-T7 Primer, 0.8 mM MnCl2, 1 U RNase inhibitor,
10 U Superscript III (Invitrogen), followed by reaction termination
at 65uC for 10 min. RT-PCR was carried out with the Epicentre
Biotechnologies TAQurate
TM GREEN Real-Time PCR Master-
mix kit and the LightCycler System, using for each RT-PCR run
and primer pair two replicates of non-template controls and two
replicates of template samples based on the following reaction
conditions: initial denaturation for 135 sec at 95uC, followed by 35
cycles of 5 sec at 94uC, 15 sec at 60uC and 15 sec at 72uC
(temperature transition rate of 20uC/sec). Amplification was
followed by a melting-temperature identification cycle in order
to assess PCR product purity (10 sec at 95uC, cooling to 60uC
(temperature transition rate of 20uC/sec), followed by slow heating
to 95uC (temperature transition rate of 0.1uC/sec)).
For N2, RT-PCR was performed by the Microarray Facility of
Tuebingen University, Germany, using the LightCycler System
480 (Roche Diagnostics). cDNA was synthesized with the
QuantiTect cDNA Synthesis Kit (Qiagen) using 0.5 mg RNA an
incubation for 15 min at 42uCi n1 6RT buffer, 1 mM per primer
mix (oligo-dT plus random hexamer primer), and reverse
transcriptase, followed by reaction termination at 95uC for
5 min. RT-PCR generally followed the above protocol using a
1:10 cDNA dilution and analysis in 384-well plate format. For
each primer pair, one replicate of a non-template control and
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5 ml2 6 QuantiTect SYBR Green Mix, 300 mM forward and
reverse primer, and either 2 ml cDNA (equivalent to 5 ng total
RNA) or no cDNA (non-template control). The reaction consisted
of initial denaturation for 15 min at 95uC, followed by 45 cycles of
45 sec at 95uC, 20 sec at 55uC, and 15 sec at 72uC. After
amplification the melting curve was recorded as above.
Expression data was obtained as CT values, which corresponds
to the cycle number of the amplification reaction, at which the
fluorescence of the sample exceeds the background level for the
first time, and which were measured within the linear amplifica-
tion ranges. Linear regression was used for baseline correction of
each sample as implemented in the program LinRegPCR (http://
LinRegPCR.nl) [69,70]. Analysis of relative gene expression
followed the comparative 2
2DDCT method [55]. Transcription
differences larger than 2 or smaller than 22 were then taken as an
indication for significant differential gene expression. A significant
difference from 0 was additionally evaluated with t tests and an
adjustment of significance levels according to FDR. The statistical
analyses were performed with the programme JMP 8.0 (SAS Inst.
Inc.) and the graphical summary was produced with SigmaPlot
11.0 (Systat Software Inc.).
Functional analysis of selected lysozyme genes
We investigated the role of the protist-type lysozymes lys-2, lys-
5,and lys-7 in defense against pathogenic Bt by gene knock-out and
transgenic lines with gene overexpression, followed by phenotypic
analysis. Resistance was evaluated as survival rate and infection
load. We furthermore assessed nematode body size, feeding rate
and population size, the latter being a compound fitness measure
determined by reproductive rate and developmental time that
indicates the pace at which worms could colonize a new habitat.
Population size and body size assays were performed in 5 cm
(diameter) ‘‘wormballs’’ containing PF medium [46,71]. The
wormballs were inoculated with 700 ml bacterial suspensions
(350 ml per half) containing E. coli OP50, and - in a 1:10 dilution -
either Bt18247 or DSM350 (final Bt concentration of 1.5610
9
spores/ml). All other assays were performed in 3 cm petri dishes
containing PF medium.
The survival rate of the KO mutants was examined using a
total of 20 replicates per treatment combination (two runs with
ten replicates). The survival assays for the transgenic worms were
conducted on three different dates with five replicates per run
yielding 15 replicates in total, with the exception of MY1022 and
all strains on the non-pathogenic control, for which ten replicates
were assayed. Ten L4 hermaphrodites per worm strain were
transferred manually to each plate. Survival rate of the worms
was checked daily for seven days by recording the number of
alive worms, dead worms and lost worms (e.g., dead worms on
the edge of the agar plate, lost worms on day of transfer or alive
worms on day 7). Worms were transferred to fresh plates every
other day.
Body size was measured after 8 h Bt exposure (either control or
nematocidal strain) in two independent runs with five replicates
per run and treatment combination. Infection load was deter-
mined for three to five surviving worms exposed to pathogenic Bt
for 8 h using five replicates per strain. For body size and infection
load measurements, worms were transferred into a drop of M9
buffer on a diagnostic microscope slide, frozen at 220uC, and then
photographed with a LeicaDFC 320 camera (Leica Microsystems
Imaging solutions Ltd, Cambridge, UK) attached to a Leica DM
5000 B microscope (Leica Microsystems, Wetzlar, Germany),
using Normarski settings and 106magnification for body size and
1006magnification for infection. Body size was measured as the
two-dimensional area of an animal using the program ImageJ
[72], followed by calculation of the average body size for each
replicate. The infection level was inferred from surviving worms
using a similar approach as previously described [46] based on
seven infection categories: (i) no infection; (ii) no more than 20
spores in the gut; (iii) more than 20 and no more than 100 spores,
accumulation in either the anterior or posterior part of the gut, no
vegetative cells; (iv) as category iii, but accumulations in both
anterior and posterior part of the gut; (v) more than 100 spores
with massive accumulations in the anterior and/or posterior part
of the gut, first intestinal cells destroyed, no vegetative cells; (vi) as
category v, but with vegetative cells inside the gut; (vii) as category
vi but spores and vegetative cells in high concentrations in all parts
of the gut and body. For each replicate, we calculated an overall
infection index as the average from at least three and maximal five
surviving worms. For body size and infection load analysis, we
excluded replicates with data from less than three surviving
worms.
Feeding rate was assessed on minimum agar (3.4% w/v),
inoculated with 40 ml of a mixture of E. coli (1.5610
10 cells/ml)
and Bt (either the nematicidal or the nonpathogenic BT;
concentration in both cases, 3.67610
7 spores/ml). Ten L4 were
transferred onto each plate. After 8 h, the feeding rate was
determined for five individuals from within the bacterial lawn by
counting pharynx grinder movements within a 30 s period [46].
Data was considered from 5 independent experiments, yielding 25
worms per factor combination. Nematode population size was
examined in parallel to the above assays using a total of ten
replicates per treatment combination (two runs with five replicates
each). Ten L4 worms per strain were transferred manually to each
wormball. After five days the total number of worms per
population was determined.
Table 1. Primer used for lysozyme qRT-PCR gene expression
analysis.
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and population size were separately tested for significance using
pair-wise comparisons of KO mutants with corresponding N2
controls within each treatment, using rank-based Wilcoxon tests.
Differences in infection load were evaluated with a One-Way-
ANOVA, followed by Tukey HSD post-hoc tests. Differences in
survival rate were evaluated with the Kaplan-Meier approach
followed by log-rank tests. KO-mutants were always compared to
the wildtype N2. Transgenic worms were compared to N2 and
also the corresponding KO mutant strain. Significance levels were
adjusted using FDR [68]. The statistical analysis was performed
with the programme SPSS 16.0 (SPSS Inc.).
Supporting Information
Table S1 Lists of significantly differentially regulated
genes upon exposure of three C. elegans strains to
nematocidal B. thuringiensis B-18247.
(XLS)
Table S2 Summary of the significantly differentially
regulated genes upon pathogen exposure of C. elegans.
(XLS)
Table S3 Phenotypes of lysozyme knock-out mutants.
Control treatment was performed with the non-nematocidal Bt
DSM-350, the pathogen treatment with the nematocidal Bt strain
B-18247. Phenotypic measures are given as means and, in
brackets, standard errors. Survival rate was followed daily over 7
days (mean given as number of days of survival), infection load was
determined after 8 h, and body size (multiplied by 10
2 in mm
2)
was determined after 1 day, and population size after 5 days. After
8 h, the pumping rate was determined for five individuals by
counting the pharynx grinder movements within a 30 s period.
Infection load under control conditions was not determined (nd).
Survival experiments were performed on two separate dates for a
total of 20 replicates per treatment combination (10 replicates per
date and treatment combination). For body size (10 replicates in
total) and infection load (5 replicates in total), replicates were
excluded if less than 3 worms were available for analysis. Survival
rates were analysed using the Kaplan-Meier approach followed by
a post-hoc log-rank test for comparisons between the KO mutants
and N2. Differences in infection load were evaluated using One-
Way-ANOVA followed by the post-hoc Tukey HSD test for
pairwise comparisons between KO mutants and N2. Statistical
analyses of differences in pumping rate, body size and population
size were based on rank-based Wilcoxon test, p-values were
adjusted using FDR to account for multiple testing. For all
nematode strains, exposure to pathogenic Bt (factor Bt treatment)
led to a significant decrease in survival rate, pumping rate, body
size, and population size. Significant differences between N2 and
the KO mutants under pathogenic conditions are shown in bold
and indicated by *. The infection load of lys-7(ok1386) only
showed a trend in being different to N2 (indicated by
+).
(DOCX)
Table S4 Survival rate of lysozyme knock-out mutants
and transgenic worms on pathogenic and non-patho-
genic B. thuringiensis. The pathogen treatment was per-
formed with Bt strain B-18247. Survival measures are given as
means and, in brackets, standard errors. Survival rate was
followed daily over 7 days. The survival experiment on the
pathogen was repeated on 3 separate occasions for a total of 15
replicates per strain. Only 10 replicates were assayed on the
pathogen for N2+lys-5 (i.e., overexpression of lys-5 in N2
background) and all strains on the non-pathogenic control.
Under control conditions, individuals of almost all strains
survived until the end of the assay period of seven days. Survival
rates were analysed using the Kaplan-Meier approach followed
by a post-hoc Log-rank test for comparisons between the KO
mutants and the corresponding transgenic strain as well as for
comparisons between the transgenic strains and N2. Significant
differences between transgenic strains and the corresponding KO
mutant are shown in bold and indicated by *. Significant dif-
ferences between N2 and transgenic strains are indicated with
+.
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